Liver/Biliary Disorders News

LONDON — Younger-onset type 2 diabetes increased the risk for liver-related events among patients with nonalcoholic fatty liver disease, according to research presented at the International Liver Congress.

LONDON — The Gender-Equity Model for Liver Allocation and its sodium-corrected variant were better predictors of mortality or delisting in patients awaiting liver transplantation and may correct gender disparities, according to research.

LONDON — Therapy combining small interfering RNA, capsid assembly modulator and nucleotide analogue reduced HBsAg levels over 24 weeks compared with standard therapy, according to a presenter at the International Liver Congress.

LONDON — An outbreak of acute, severe hepatitis of unknown etiology in children has grown to 894 cases across 33 countries, according to data presented during a media briefing at the International Liver Congress.

ATLANTA — Adults with overweight or obesity and nonalcoholic fatty liver disease, or NAFLD, had a significant reduction in liver fat and inflammation with daily subcutaneous growth hormone administration, according to a speaker.

After a nearly 3-year hiatus, the International Liver Congress 2022 will resume as a hybrid experience with an expansive scientific program that emphasizes the importance of technology-driven research and development.

Expanding access to split liver transplants and adopting a “split first” policy on donor livers will significantly reduce mortality on the pediatric waitlist, noted a presenter at the American Transplant Congress 2022.

Data reported in Morbidity and Mortality Weekly Report did not demonstrate an increase in pediatric hepatitis or adenovirus types 40/41 above pre-COVID-19 pandemic baseline levels.

An updated MELD 3.0 amends existing sex-based disparities in access to liver transplantation among women, according to a presenter at the American Transplant Congress 2022.

Although the development and use of biomarkers in liver transplantation has progressed in recent years, challenges and limitations remain, according to presenters at the American Transplant Congress 2022.